Part of its $4.2 billion Centennial Campaign, the gift, which includes matching funds from other donors, will provide unrestricted funds to accelerate research, innovative clinical care, and educational priorities within the digestive disease division. In recognition of the Manoukians' support, the university will name the unit and its medical plaza in their honor.
Vatche Manoukian has been involved in a wide range of businesses, including property investment, retail, pharmaceuticals, biotechnology, entertainment, and renewable energy. He and his wife support children's charities around the world, including the National Society for the Prevention of Cruelty to Children; the U.S. Fund for UNICEF, on whose board Manoukian serves; and the Prince Albert II of Monaco Foundation. They also support the Royal Opera House in London.
"Innovation requires both leadership and investment," said Eric Esrailian, co-chief of the Division of Digestive Diseases and Lincy Foundation Chair in Clinical Gastroenterology in the Geffen School of Medicine. "Tamar and Vatche's exceptional philanthropy will help ensure that UCLA can continue unraveling the mysteries of digestive diseases, make transformative scientific discoveries, and develop the physician leaders of the future. Their unrestricted gift gives the division flexibility that is essential as we advance our highest educational, research and patient care priorities."